Background: During the diagnosis and treatment of non–small cell lung cancer (NSCLC), detecting the risk of its recurrence in an early phase is still challenging. Recent studies have investigated the ...

Implanting living cells as long-term drug producers could transform treatment for numerous diseases, but it is difficult to house the tiny workers in quantities high enough to ensure dosage needs are ...

Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0 This guideline consolidates all previous updates and reflects the body of evidence informing ...

Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using stem cells taken from only one person. These chips simulate breathing motions and lung ...

Squamous cell carcinoma treatment varies by stage, involving surgery, radiation, and systemic therapies based on cancer progression and patient health. Stage 1 focuses on tumor removal, Stage 2 ...

Patients with locally advanced non-small cell lung cancer (NSCLC) who undergo concurrent chemoradiotherapy (CCRT) followed by consolidation immunotherapy show heterogeneous survival outcomes. Accurate ...

Abstract: Non-small cell lung cancer (NSCLC) is an extremely common subtype of lung cancer. Accurate early diagnosis and identification of NSCLC offers more effective possibilities for early ...

To evaluate and compare the predictive performance of machine learning methods using clinical-semantic, radiomic, and combined features in distinguishing squamous cell carcinoma (SCC) from ...

The two main categories for lung cancer are small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Large cell lung cancer (LCLC) is a type of NSCLC. While the conditions share some ...

Results of the cross-sectional study showed that impaired lung function was associated with an increased risk for spondyloarthritis. Impaired lung function — particularly preserved ratio impaired ...